Trials / Completed
CompletedNCT01719497
Imaging of Cannabinoid 1 Receptors Using [11C]OMAR and PET
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 74 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present study is to conduct a human trial of \[C-11\]OMAR, a new PET imaging agent for the brain cannabinoid type 1 receptors (CB1), to determine its pharmacokinetics and binding characteristics.
Detailed description
This is a pilot, 2-part study to assess the kinetics of radioactivity in medically healthy subjects, subjects with alcohol dependency (AD), and obese subjects following the intravenous administration of the imaging agent \[C-11\]OMAR.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [C-11]OMAR | PET radioligand |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2012-11-01
- Last updated
- 2022-07-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01719497. Inclusion in this directory is not an endorsement.